Krónikus limfoid leukémia (CLL): vizsgálatok itt: Szingapúr

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Where

  Singapore

  Életkor

  18 év and over

  People

  500 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06973187 · EU 2025-522860-34-00